In March, HIPRA introduced HIPRABOVIS® BALANCE in Algeria - an innovative vaccine for the prevention of reproductive and respiratory infectious disease in cattle. More than 250 professionals attended the three events organized around the country, making the launch a great success.

For the launch of HIPRABOVIS® Balance, HIPRA organized three technical sessions under the title "Management of the main reproductive and respiratory bovine diseases: from clinical signs to prevention" with the participation of Dr. Calixte Bayrou (Pathology Department of the Faculté de Médecine Vétérinaire de Liège) and Dr Mohamed Ben Menadi (Technical and Marketing Manager HIPRA North Africa).

The event was attended by professionals from the three different regions (Algiers, Sétif and Oran) involved in the fattening and dairy business. The veterinarians took the opportunity to update their knowledge on BVD and BRD (Bovine Respiratory Disease) and discuss with experts various topics related to the aetiology, epidemiology, diagnosis and prevention of the diseases. Of special interest was the strategic use of vaccination in order to control viral circulation. In addition, Vincent Robles (Brand Manager HIPRA) presented the vaccine’s main features and the results obtained with HIPRABOVIS® BALANCE, a 50% reduction in clinical signs of pneumonia and 71.5% foetal protection against BVD having been demonstrated.

With the launch of HIPRABOVIS® BALANCE, HIPRA continues to consolidate its position as a leader in prevention, bringing to market distinctive and innovative products for animal health.